Skip To Content

News & Events

Given the activity level of our attorneys, we are confident in showcasing the various matters that our clients have given us the privilege to work on and approved to post here.

Posts

  • October 13 2017

    Intellipharmaceutics International Inc. announced the closing of their Registered Direct offering in the amount of $4,000,000.  EG&S acted as counsel to the Placement Agent.

     

  • October 12 2017

    Cellectar Biosciences Inc. announced the closing of their Registered Direct offering in the amount of $7,766,164.  EG&S acted as counsel to the Placement Agent.

  • October 11 2017

    Rimini Street, Inc., a global provider of enterprise software products and services, announced the closing of its merger with special purpose acquisition company GP Investments Acquisition Corp. The combined company will retain the Rimini Street, Inc. name and will trade on Nasdaq as “RMNI.”  The transaction was valued at $50,000,000. Cowen served as financial and capital markets advisor to Rimini Street, and EG&S acted as counsel to Cowen.

  • October 04 2017

    Jaguar Health, Inc. announced the closing of their public underwritten offering of common stock in the amount of $4,250,000.   EG&S acted as  counsel to the placement agent, Maxim Group, LLC.

  • October 04 2017

    Jaguar Health, Inc. announced the closing of its public underwritten offering of common stock in the amount of $4,250,000.   EG&S acted as counsel to the underwriter, Maxim Group, LLC.

  • October 04 2017

    Aethlon Medical, Inc. announced the closing of their Registered Direct offering in the amount of $6,000,000.  EG&S acted as counsel to the Placement Agent.

  • October 03 2017

    The Deal’s exclusive League Table ranking tracks PIPEs that raise at least $1 million between January 1 and September 15, 2017.  Ellenoff Grossman & Schole LLP was the top-ranked agent legal counsel with eight placements advised and tied for second, with four placements advised for investor legal counsel.

    Click here to read the full report.

  • October 02 2017

    Nacuity Pharmaceuticals, Inc. announced the closing of their private placement of preferred stock and warrants in the amount of $9,422,000 over three closings.  EG&S acted as counsel to Maxim Group LLC.

“It’s with genuine appreciation to all of our clients that we are in a position to achieve and maintain our leadership position in so many areas.”